Fixing a leaky heart valve to improve heart failure treatment
Part of Heart & circulation clinical trials.
This study tests a procedure to fix a leaky heart valve (mitral valve) in people with heart failure, with the goal of helping them tolerate and benefit from standard heart failure medicines. It asks whether adding this valve repair to optimized medicines is better than medicines alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart's pumping strength is 40% or lower
- You have a leaky mitral valve that is moderate to severe
- Your heart failure medicines are not yet at the target dose
- You have one or more risk factor that makes it hard to increase medicines, like low blood pressure, kidney problems, or high potassium
- You have had symptoms like shortness of breath or fatigue with activity, or have been hospitalized for heart failure recently
- A heart doctor believes the leaky valve can be fixed with a procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called transcatheter edge-to-edge repair (TEER) for people with a specific type of heart valve leak (functional mitral regurgitation) that is causing heart failure symptoms. The procedure is less invasive than open-heart surgery and aims to improve symptoms and quality of life.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial tests a minimally invasive procedure to repair a leaky mitral valve that only becomes severe during exercise. If you have mild to moderate leakage at rest that gets worse when you are active, this study may help determine if the repair improves your symptoms and heart function.
This trial tests whether a catheter-based procedure can safely repair a leaking mitral heart valve in people who still have symptoms despite best medical treatment. If you qualify, it may improve symptoms and heart function without open-heart surgery.
This trial studies an “epicardial” device placed during planned heart surgery to reduce mitral valve leaking (“mitral regurgitation”). If you have moderate-to-severe valve leak from ischemic heart disease and are already scheduled for heart surgery, this may help improve how well the valve works.
This trial compares two treatment approaches for people with heart failure and a leaky mitral valve (mitral regurgitation). It aims to find which strategy leads to better outcomes. You may be eligible if your heart function is reduced and you have symptoms despite standard treatments.
Hear when a new Mitral Regurgitation Functional trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.